TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Increase in duration of activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: birth-weight regaining time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time of reaching 418.4 kJ/(kg.d) by enteral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: morbidity of gastric residue
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients receiving rescue therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Confirmed hypoglycaemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in κ FLC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in λ FLC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-dialysis κ/λ ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement or no change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MEF10 change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bath hot water temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Happiness with bath hot water temperature
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reporting temperature as too hot
Endpoint domain: Adverse events/effects
Primary endpoint: Lesion conspicuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTDIvol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contrast media utilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent predicted FVC from baseline to Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: percentage of subjects with decline in percent predicted FVC greater than or equal to 10% at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality indicators at hospital discharge
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Increased awareness of antibiotic resistance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Greater self-confidence in reducing antibiotic prescribing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in consultation style and antibiotic prescribing behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of allergic contact reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GCSI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: appetite improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital-acquired pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Mean HbA1c values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency and severity of adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: freedom from late major complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reinfarction
Endpoint domain: Mortality/survival
Primary endpoint: Amygdala response to emotional stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Menstrual blood loss (MBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (QOL) in physical aspects
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Correction of anemia related to menorrhagia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to fulfil discharge criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Angiographic success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day death or major stroke
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of correct indications on the day of inclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean cost saved per 100 patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: safety planning rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Non-Nasal Symptom Score (TNNSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discharge with antihypertensive medication
Endpoint domain: Adverse events/effects
Primary endpoint: failure rate of NOM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average positive staining area percentage of IL-17 and MPO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CTFC (Corrected Thrombolysis in Myocardial Infarction flow grade)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of subjects with a detectable increase in cardiac troponin I (cTnI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fatal adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of new or increased symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnosis of lytic bone changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: assessment of fracture risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prolactin (PRL) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Galactorrhea incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical signs improvement (BPRS and PANSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of frequency of seizures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: positive expectations pertaining to partner's support for contraception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Breastfeeding initiation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of stopping breastfeeding at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of stopping breastfeeding at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of CV death, MI, and stroke
Endpoint domain: Mortality/survival
Primary endpoint: successful pleurodesis at day 35
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary glucose excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change in blood viscosity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: fluid retention rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in premenstrual mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in free testosterone (FT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Cooling effect on oral temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cooling effect on ear canal temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dexamethasone concentration in aqueous humor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in serum lipids (TC, LDL-C, VLDL-C, triglycerides)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in blood pressure (systolic and diastolic)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: menopause-related symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reaction time improvement in working memory task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 3-month survival gain
Endpoint domain: Mortality/survival
Primary endpoint: decreased specialty use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: decreased yearly hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Perimetry mean deviation values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline BCVA at month 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects achieving BCVA ≥ 20/40 at month 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline central subfield thickness at month 15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median numbers of micturitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grading accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Understaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reading time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IAA levels over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: genital irritation
Endpoint domain: Adverse events/effects
Primary endpoint: Exercise adherence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Levels of interleukin-8 in amniotic fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Presence of motional artifacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Image acquisition parameters (examination length, examination duration, radiation dose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vascular contrast rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Compliance with the first prenatal appointment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for specific advice or follow up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total cholesterol concentration greater than or equal to 8 mmol/l
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial lipid content of large VLDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: IDL cholesterol AUCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LDL triglycerides AUCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retention of restorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores of clinical symptoms and function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBDQ-Total Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: IBDQ-Bowel
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: IBDQ-Systemic
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Flow-mediated dilation (FMD) after lower arm occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall subjective pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in global assessment areas
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improved understanding of the TEP hernia repair
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Increased willingness to offer the operation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Diagnostic accuracy of SPECT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Most bothersome symptom (MBS) free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: HF mortality or HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: all-cause mortality or all-cause hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: knee external rotation at initial ground contact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h trough FEV(1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Intravascular hemolysis markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total 8‐iPF2alpha‐III concentrations in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection of placental malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sensitivity of placental impression smears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Specificity of placental impression smears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Patient satisfaction with interaction and information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in behavior towards better oral hygiene
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Treatment response classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of sick days
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: total mSvdHS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: JSN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ERO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Decrease in HAM-A score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in delayed memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in reasoning ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Volume delivered by SIRs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: one-year composite adverse event rate
Endpoint domain: Adverse events/effects
Primary endpoint: ischemic target vessel revascularization (TVR) at 30 days
Endpoint domain: Adverse events/effects
Primary endpoint: angiographic restenosis
Endpoint domain: Adverse events/effects
Primary endpoint: urinary symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drowsiness
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma BH4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: average amount of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: detectable antibody responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: replication of vaccine virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive or functional impairment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rates of breast recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Assessment of cosmetic outcome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of AD completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' assessment of managing dyspnoea
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patients' assessment of lung symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ability to react to signs of exacerbation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in anti-rotavirus serum IgA antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cotinine-confirmed self-reported 7-day abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum flexural strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proximal DVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Pulmonary embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Hours of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilator settings changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: recovery room time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery room charges
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Interlobar artery RI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cortical vessel RI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: coronary artery disease events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lp-PLA2 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: bladder sensory thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median age of CIN3 diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCT and CRP levels as diagnostic markers of bacterial GE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of renal impairment associated with elevated PCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Occurrence of nasal PPB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Retina reattachment rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproliferation rate
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative hemorrhage frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Researcher trust
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Stroke knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Best Corrected Visual Acuity (BCLCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean sitting systolic BP (MSSBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: methacholine-induced vasodilatation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of emergency visits for asthma attacks
Endpoint domain: Adverse events/effects
Primary endpoint: QuickDASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric pain-rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV RNA levels <400 copies/ml at delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Elective caesarean delivery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of infant infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Arterial puncture rates
Endpoint domain: Adverse events/effects
Primary endpoint: Left ventricular end-diastolic volume index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in overall Neer score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean HF/TP during sleeping period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LF/HF ratio during initial 3-h sleeping period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality-adjusted life years
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incremental cost per quality-adjusted life year
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Recovery of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in percent predicted FEV₁
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: side effects (palpitations)
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of PSE 7 to 8 years after ischemic stroke
Endpoint domain: Mortality/survival
Primary endpoint: Cumulative incidence of pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Chinese medicine dementia syndromes scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes